Department of Otolaryngology, Head and Neck Surgery, Nantes University Hospital, Nantes, France.
Department of Otolaryngology, Head and Neck Surgery, Clinique Confluent, Nantes, France.
J Int Adv Otol. 2023 Jan;19(1):70-73. doi: 10.5152/iao.2023.22716.
Langerhans cell histiocytosis is a rare condition affecting the temporal bone in up to 60% of cases. Symptoms are non-specific and the differential diagnosis includes infection, benign lesions such as cholesteatoma, and malignant lesions of the skull base. Here, we report the case of a 14-yearold child referred with chronic ear discharge, and background of multifocal Langerhans cell histiocytosis 9 years prior. Recurrence of Langerhans cell histiocytosis was initially suspected and systemic treatment was considered. Further imaging workup and surgical exploration of the mastoid showed a secondary acquired cholesteatoma arising from a dehiscent posterior ear canal wall. Surgical removal of the cholesteatoma was performed with a canal wall down procedure. We review the presentation and management of temporal bone Langerhans cell histiocytosis. We recommend that cholesteatoma should be considered in case of recurrence of otological symptoms in patients with a background of Langerhans cell histiocytosis.
朗格汉斯细胞组织细胞增生症是一种罕见的疾病,60%的病例会累及颞骨。症状无特异性,鉴别诊断包括感染、胆脂瘤等良性病变,以及颅底恶性病变。本文报告 1 例 14 岁患儿,因慢性耳溢液就诊,9 年前曾有多发性朗格汉斯细胞组织细胞增生症病史。最初怀疑为朗格汉斯细胞组织细胞增生症复发,并考虑全身治疗。进一步的影像学检查和乳突探查显示,继发于后耳道壁开窗的获得性胆脂瘤。采用完壁式乳突切开术切除胆脂瘤。本文回顾了颞骨朗格汉斯细胞组织细胞增生症的临床表现和治疗。我们建议,对于有朗格汉斯细胞组织细胞增生症病史的患者,若出现耳部症状复发,应考虑胆脂瘤的可能性。